Antibody-dependent cytotoxicity against Trypanosoma rhodesiense mediated through an alternative complement pathway.
A quantitative in vitro method was used to examine the role of classical and alternative pathways of complement activation in cytotoxicity against African trypanosomes by immune serum. This assay is based on the estimation of the extent of antibody-mediated cytotoxicity by measurement of inhibition of incorporation of [(3)H]leucine as an indicator of trypanosome metabolic integrity. To determine which pathway(s) is activated during cytotoxic events, complements sufficient in all components (C4S) and deficient in C4 (C4D) were used. Immune inhibition of [(3)H]leucine uptake by trypanosomes was observed in the presence of both complement sources. Treatment of C4S or C4D serum with cobra venom factor or disodium ethylenediaminetetraacetic acid abolished antibody-mediated cytotoxicity as well as immune hemolysis, thus suggesting the requirement for late-acting complement components. Ethyleneglycol-bis(beta-aminoethyl ether)-N,N-tetraacetic acid had no effect on inhibition of leucine incorporation, whereas immune hemolysis was inhibited, suggesting that cytotoxicity did not require C1 activation, a Ca(2+)-dependent event. The dependence of the cytotoxic process on Mg(2+) and not Ca(2+) ions and the fact that C4D guinea pig serum is fully active in trypanosome cytotoxicity indicate that an alternative pathway of complement activation is sufficient for activity.
D000818:Animals; D000937:Antigen-Antibody Reactions; D003181:Complement C4 / Q000172:deficiency; D003165:Complement System Proteins / Q000378:metabolism*; D003602:Cytotoxicity, Immunologic / Q000187:drug effects; D004492:Edetic Acid / Q000494:pharmacology; D004533:Egtazic Acid / Q000494:pharmacology; D004546:Elapid Venoms / Q000494:pharmacology; D008297:Male; D051381:Rats; D014345:Trypanosoma / Q000276:immunology*
D003181:Complement C4; D004546:Elapid Venoms; D004533:Egtazic Acid; D003165:Complement System Proteins; D004492:Edetic Acid